Pfizer is recalling intravenous drugs with floating matter in them, warning they could potentially kill weakened patients, after U.S. regulators had warned about the worries prior to the recall. The products — made by Claris Lifesciences and distributed in the U.S. by Pfizer — are the antibiotics metronidazole and ciprofloxacin and a drug used to prevent nausea and vomiting caused by surgery and chemotherapy, named ondansetron.
The Food and Drug Administration warned doctors and hospitals not to use the drug because of worries the floating matter meant the products weren’t sterile. Pfizer says non-sterility in intravenous drugs could be fatal for patients with weakened immune systems. In addition to the recall, Pfizer is halting its distribution of all sterile injectable products and IV bags licensed from Claris.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.